Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Clinical trial NCT00753649 · COMPLETED

Trial details

NCT number: NCT00753649
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Tetanus Poliomyelitis Diphtheria Haemophilus Influenzae Type b Acellular Pertussis

Start date: 2008-09-23
Primary completion: 2013-03-12
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.